ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1434

Patient-Proxy Agreement on Health-Related Quality of Life in Juvenile Fibromyalgia Syndrome

Sabrina Gmuca, Audrey Urquhart and David D. Sherry, Pediatric Rheumatology, Children's Hospital of Philadelphia, Philadelphia, PA

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: fibromyalgia, Health Assessment Questionnaire, patient outcomes and pediatric rheumatology

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 22, 2018

Title: Pediatric Rheumatology – Clinical Poster II: Autoinflammatory Disorders, Scleroderma, and Miscellaneous

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: The administration of proxy-reported health-related quality of life (HRQoL) measures in the assessment of juvenile fibromyalgia syndrome (JFMS) is common but its added clinical value to patient-reported measures is unclear. The aim of this study was to examine the level of agreement between patient- and proxy-reports of the Pediatric Quality of Life Inventory Short Form 15 (PedsQL SF-15) among children with JFMS and to examine potential factors influencing patient-proxy agreement. Given the strong parent-child pain relationship, we hypothesized good agreement.

Methods: This was a cross-sectional cohort study of children 8-17 years old presenting for initial evaluation to a pediatric rheumatology pain clinic from April 2017 – April 2018. Included subjects met the 2010 American College of Rheumatology criteria for fibromyalgia syndrome. All patients and proxies completed electronic questionnaires, including the PedsQL SF-15, as part of routine clinical care. Additional information collected included age, sex, race, ethnicity, verbal pain score (0-10), and pain duration (months). Descriptive statistics were performed to assess patient characteristics.  Intra-class correlation (ICC) estimates and their 95% confidence intervals were calculated based on a mean-rating, absolute-agreement, 2-way mixed-effects model to examine patient-proxy agreement on the PedsQL SF-15. We performed multiple regression analyses to explore the relationship between different independent variables and patient-proxy agreement.

Results: Over the study interval, 54 patient-proxy pairs met criteria and completed the HRQoL measures. The majority of patients were non-Hispanic (94%), Caucasian (79%), and female (83%). The median age at time of presentation was 15 years (IQR: 14, 16). The median verbal pain score was 5 (IQR: 4, 7). Median duration of pain was 24 months (IQR: 12-36). Cronbach’s alpha coefficient for the PedsQL SF-15 exceeded 0.70. All domains demonstrated good to excellent agreement between patients and proxies (Table 1). Multiple regression analyses, adjusting for patient sex, Caucasian race, age, current pain level and pain duration showed that the greater the child’s pain, the greater the patient-proxy agreement on the Total Scale (β = -1.20, p<0.05) and the Emotional Functioning Scale (β = -2.03; p<0.05).

Conclusion: The high levels of patient-proxy agreement in this study suggest that children with JFMS and their parents communicate their feelings and opinions well to one another and this agreement is associated with greater pain severity in the child. These findings reflect the enmeshed relational and communication styles between children with JFMS and their parents. In order to facilitate adolescents becoming partners in their own healthcare and to decrease the burden of multiple questionnaires, we propose focusing on children’s own perceptions of HRQoL.

 


Disclosure: S. Gmuca, None; A. Urquhart, None; D. D. Sherry, None.

To cite this abstract in AMA style:

Gmuca S, Urquhart A, Sherry DD. Patient-Proxy Agreement on Health-Related Quality of Life in Juvenile Fibromyalgia Syndrome [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/patient-proxy-agreement-on-health-related-quality-of-life-in-juvenile-fibromyalgia-syndrome/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/patient-proxy-agreement-on-health-related-quality-of-life-in-juvenile-fibromyalgia-syndrome/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology